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Abstract
We improved our inductively coupled plasma mass spectrometry (ICP-MS) whole blood method 
[1] for determination of lead (Pb), cadmium (Cd), and mercury (Hg) by including manganese (Mn) 
and selenium (Se), and expanding the calibration range of all analytes. The method is validated on 
a PerkinElmer (PE) ELAN® DRC II ICP-MS (ICP-DRC-MS) and uses the Dynamic Reaction Cell 
(DRC) technology to attenuate interfering background ion signals via ion-molecule reactions. 
Methane gas (CH4) eliminates background signal from 40Ar2+ to permit determination of 80Se+, 
and oxygen gas (O2) eliminates several polyatomic interferences (e.g. 40Ar15N+, 54Fe1H+) 
on 55Mn+. Hg sensitivity in DRC mode is a factor of two higher than vented mode when measured 
under the same DRC conditions as Mn due to collisional focusing of the ion beam. To compensate 
for the expanded method’s longer analysis time (due to DRC mode pause delays), we 
implemented an SC4-FAST autosampler (ESI Scientific, Omaha, NE), which vacuum loads the 
sample onto a loop, to keep the sample-to-sample measurement time to less than 5 min, allowing 
for preparation and analysis of 60 samples in an 8-h work shift. The longer analysis time also 
resulted in faster breakdown of the hydrocarbon oil in the interface roughing pump. The 
replacement of the standard roughing pump with a pump using a fluorinated lubricant, Fomblin®, 
extended the time between pump maintenance. We optimized the diluent and rinse solution 
components to reduce carryover from high concentration samples and prevent the formation of 
precipitates. We performed a robust calculation to determine the following limits of detection 
(LOD) in whole blood: 0.07 μg dL−1 for Pb, 0.10 μg L−1 for Cd, 0.28 μg L−1 for Hg, 0.99 μg L−1 
for Mn, and 24.5 μg L−1 for Se.
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1. Introduction
The Centers for Disease Control and Prevention’s (CDC) Environmental Health Laboratory 
at the National Center for Environmental Health (NCEH) uses inductively coupled plasma 
mass spectrometry (ICP-MS) to measure trace and toxic elements in people’s blood and 
urine to detect harmful exposures of environmental chemicals in populations [2,3]. These 
measurements are made as part of ongoing assessments of the U.S. population’s exposure, 
such as the National Health and Nutrition Examination Survey (NHANES), as well as for 
emergency response situations due to accidental or intentional acute exposures. In national 
survey applications, the sensitive, multielement capabilities of ICP-MS permit the efficient 
low-level quantitation of multiple trace and toxic elements. In emergency response 
situations, the fast analysis and wide dynamic range of ICP-MS permits the quantification of 
toxic elements from both chronic and acute exposures.
Lead, cadmium, and mercury are toxic to humans and show only deleterious effects on 
human health. The Agency for Toxic Substances and Disease Registry (ATSDR) has 
published Toxicological Profiles for these elements [4–6] which list numerous health effects 
based on the route of exposure (inhalation, oral, or dermal) including death, chronic 
diseases, permanent neurological damage, or subclinical effects. The effects of mercury can 
depend on the type of mercury exposure (inorganic vs. organic) although both are 
considered toxic. Total blood mercury concentrations, such as those measured in this 
method, are considered indicative of dietary intake of organic mercury, particularly methyl 
mercury [7], although inorganic and ethyl mercury can also be measured in blood [8]. Blood 
lead and blood cadmium measurements are widely accepted as an indicator of recent and 
long-term exposures [7]. Until 2012, children were identified as having a blood lead “level 
of concern” if the test result is 10 μg dL−1 or higher of lead in blood. CDC is no longer using 
the term “level of concern” and is instead using a reference value, currently 5 μg dL−1, to 
identify children who have been exposed to lead and who require case management [9]. The 
reference level is based on the 97.5th percentile of the four most recent years of NHANES 
blood lead data (currently 2007–2010). The method reported here will be used to produce 
the blood lead data on which the reference value is based.
Selenium and manganese each play an essential role in the human biological system if levels 
are not deficient or excessive. In humans, selenium is incorporated into selenoproteins, 
important antioxidant enzymes which help prevent cellular damage caused by free radicals. 
Free radicals are natural by-products of oxygen metabolism that may contribute to the 
development of chronic diseases such as cancer and heart disease [10,11]. Other 
selenoproteins help regulate thyroid function and play a role in the immune system [12–14]. 
There is evidence that selenium deficiency may contribute to heart disease, hypothyroidism, 
and a weakened immune system [15,16]. Symptoms of very high exposure to selenium, a 
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condition called selenosis, include gastrointestinal upsets, hair loss, white blotchy nails, 
garlic breath odor, fatigue, irritability, and mild nerve damage [17]. Manganese, an essential 
trace element, plays a role in bone mineralization, metabolism, and metabolic regulation. It 
is part of several metalloenzymes [18] and is ubiquitous in the human body. Elevated 
manganese levels are known to be neurotoxic and linked to the diagnosis of manganism 
[18,19]. Environmental human exposures are commonly due to contaminated drinking water 
[20,21] and potentially due to methylcyclopentadienyl manganese tricarbonyl (MMT), an 
anti-knocking additive in gasoline [22–24]. Manganese deficiency in humans is rare, but has 
been associated with impaired growth, reproductive function, and glucose tolerance, and 
with alterations in carbohydrate and lipid metabolism in various animal species [25]. We 
added manganese and selenium to the method to establish reference ranges for the U.S. 
population which have not previously been available.
Our laboratory began using ICP-MS for the determination of Pb, Cd, and Hg in blood 
starting with the NHANES cycle 2003–2004 [1]. That method used a calibration range 
optimized for biomonitoring applications where the normal population exposure was also 
expected to be narrow (i.e., approximately one order of magnitude between the geometric 
mean and the 95th percentile). A second ICP-MS method was developed in 2008 at the CDC 
for the analysis of Pb, Cd, and Hg in human blood [26] to be used in state and local public 
health laboratories to increase emergency response capacity within the U.S. The goal of the 
work described here was to develop a single method that achieves a wide calibration range 
suitable for high-throughput biomonitoring and emergency response applications, easily 
transferable to state and local public health labs, and also to include manganese and 
selenium.
A review of trace elements in biological fluids by Ivanenko et al. [27] lists four published 
methods [26,28–30] of whole blood analysis by quadrupole ICP-MS with a collision or 
reaction cell used to measure at least one of the elements here. Four other publications were 
identified [22,31–33] in the literature as comparable to our method. Our method has several 
important advantages. We use a straightforward sample dilution in alkali diluent and the 
diluted samples can be directly analyzed without extra sonication or centrifugation [31,32]. 
No lengthy acid digestion is required [22,28]. The diluent makeup is based on the work of 
Lutz [34] and McShane [26] which minimizes memory effects from high concentration 
samples to subsequent samples. This method requires a smaller sample volume, 50 μL of 
whole blood, to complete determination of all five elements, compared to requirements of 
100–1 mL in the literature [22,26,28–30,32]. This smaller volume is especially important 
when a patient sample needs to be split and analyzed by several methods. Our calculation of 
the method limits of detection (LOD), derived from matrix-matched calibration blanks and 
standards across numerous runs (n≥60), is more robust and statistically confident than found 
in the literature and results in comparable values, if not improved.
The severity of the human health effects from exposure to Pb, Cd, Hg, Mn, and Se 
necessitate an accurate and precise procedure. The analytical method described here 
quantifies concentrations of Pb, Cd, Hg, Mn, and Se in whole human blood using a PE 
ELAN® DRC II ICP-MS. The method is applicable to long-term biomonitoring studies to 
evaluate chronic environmental or other non-occupational exposures or to fast response 
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when acute exposure to these elements is suspected. Discussions of the method will include 
figures of merit such as accuracy, precision, limit of detection, and ruggedness under routine 
implementation.
2. Materials and methods
2.1. Instrumentation
An ELAN® DRC II ICP-MS (PerkinElmer SCIEX, Concord, Ontario, Canada) with quartz 
cyclonic spray chamber, demountable quartz torch, 2.0 mm i.d. quartz injector, and nickel 
(or platinum) sampler and skimmer cones (PE, Shelton, CT) was used. The instrument was 
equipped with an integrated DXi micro peristaltic pump and switching valve, a 1.0 mL 
sample loop (1.6 mm i.d.), and PolyPro-ST concentric nebulizer (0.25 mm i.d.) as part of the 
SC-FAST system (Elemental Scientific Inc., Omaha, NB). Peristaltic pump tubing moves the 
carrier solution through the sample loop to the nebulizer (0.76 mm i.d. “black-black”) and 
removes waste from the spray chamber (Santoprene 1.30 mm i.d. “grey-grey”) (Meinhard, 
Golden, CO). The pump was operated at 1.5 rpm, equivalent to a liquid flow rate at the 
nebulizer of 160 μL min−1. The standard instrument roughing pump, which used general 
purpose mechanical pump oil (Agilent, Santa Clara, CA), was replaced with a pump that 
uses Fomblin®, a perfluorinated polyether fluid (PerkinElmer, Shelton, CT), reducing the 
frequency of pump oil changes from biweekly (see Fig. 1) to annually. An SC-4 DX 
autosampler (Elemental Scientific Inc., Omaha, NB) was used to access diluted blood 
specimens and control the FAST sample introduction timing. Sample preparation was 
performed using a Digiflex™ semiautomatic liquid handler equipped with 10 mL diluting 
and 200 μL sampling syringes (Titertek, Huntsville, AL). Instrumental parameters used are 
presented in Table 1, and method parameters are listed in Table 2. All blood sample 
preparations are carried out in a Class II type A/B biological safety cabinet (BSC) (Nuaire, 
Plymouth, MN, USA)..
2.2. Materials and reagents
All rinse, diluent, and standards are prepared with ≥18 MΩ cm deionized (DI) water using a 
NANOpure® Diamond™ UV water purification system (Barnstead International, Dubuque, 
Iowa, USA). Concentrated hydrochloric acid (Veritas grade, GFS Chemicals, Columbus, 
OH, USA), ethylenediaminetetraacetic acid (EDTA) (Fisher Scientific, Fair Lawn, NJ), 
ammonium pyrrolidinedithiocarbamate (APDC) (laboratory grade, Fisher Scientific, 
Fairlawn, NJ), ethanol (Pharmco Products, Inc., Brookfield, CT), tetramethylammonium 
hydroxide (TMAH) (25% w/v, AlfaAesar, Ward Hill, MA), and Triton-X 100™ (J.T. Baker 
Chemical Co., Phillipsburg, NJ) were used. Single element or custom multi-element stock 
standards were purchased from various sources (High Purity Standards, Charleston, SC; 
SPEX CertiPrep, Metuchen, NJ; Inorganic Ventures, Christiansburg, VA) and traceable to 
the National Institute of Standards and Technology (NIST, Gaithersburg, MD, USA). 
Oxygen (research grade 5.0, 99.999% purity, Airgas South, Atlanta, GA) and methane 
(research grade 5.0, 99.999% purity, Airgas South, Atlanta, GA) were used in the dynamic 
reaction cell. We purchased whole human blood to matrix-match calibrators (referred to as 
base blood) and create quality control materials (Tennessee Blood Services Memphis, TN). 
Standard Reference Materials (SRMs) were purchased from National Institute for Standards 
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and Technology (NIST) (Gaithersburg, MD), and reference materials from Le Center de 
toxicology du Quebec (CTQ) (Quebec, Canada), and Wadsworth Center (Albany, NY).
2.3. Sample collection and supplies
Prior to collecting blood samples, supplies (e.g. stainless steel needle, vacutainer, cryovials, 
and tubes used in analysis) are screened to be free of significant analyte contamination. The 
screening solution and contact time depends on the intended use of the device. Stainless 
steel parts and vacutainers are screened with ≥18 MΩ cm deionized (DI) water, while all 
other devices are screened with 0.5% (v/v) HNO3. Screen solution contact time with needles 
and pipette tips approximates the normal use of the device, while it is left in sample storage 
containers overnight. The maximum allowable contribution for an element from a device is 
based on 10% of the expected population geometric mean adjusted for the volume of sample 
expected and volume of screening solution used. If the maximum allowable contribution is 
below the method LOD, then the maximum allowable contribution is set to 1.5 times the 
LOD. Blood collection tubes contain an appropriate anticoagulant (preferably EDTA).
2.4. Quality control materials
Three levels of blood quality control material pools were prepared by spiking large 
quantities (~8 L) of whole human blood purchased from Tennessee Blood Services 
(Memphis, TN) with the analytes of interest. The blood pools are mixed thoroughly and then 
dispensed into screened HDPE cryovials (FisherScientific, Pittsburg, PA) and stored at ≤
−20 °C. One-way analysis of variance (ANOVA) is used to test the hypothesis that the 
means among trays are equal. The homogeneity of the variance among trays is tested too 
(Levene’s test). P-values ≥0.05 indicate that there is no statistically significant difference 
among trays. After homogeneity test, the pools are then characterized. Three characterized 
QC pools are analyzed at the beginning and ending of each run and the multi-rule quality 
control system (MRQCS) developed by Caudill et al. [35], are used to determine if runs are 
in control.
2.5. Calibration preparation and DRC stability time
A custom multi-element stock standard is diluted with 3% (v/v) HCl (S0) in acid-washed 
Class A, glass, volumetric flasks to prepare eight spiked intermediate calibration standards 
(see Table 3). Each intermediate calibration standard is then mixed with base blood and 
diluent using the Digiflex™ pipette to prepare the matrix-matched working calibrators (S0–
S8) for an analytical run (see Table 3). The base blood pool is pre-screened and selected to 
be low in concentration of method analytes. Calibrator 0 is used as the blank for all spiked 
calibrators. The reagent blank for all patient samples, blood quality controls, and reference 
materials is prepared using DI water in place of whole blood in the dilution at the Digiflex™. 
We analyze a bulk preparation of working calibrator 2 for approximately 1 h prior to running 
the calibration curve to ensure stabilized measurements in DRC mode [36,37].
2.6. Sample preparation
During the sample dilution step, a small volume of whole blood is extracted from a larger 
whole blood patient specimen after the entire specimen is thoroughly mixed (vortexed for 
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several seconds) to create a uniform distribution of cellular components. Sample 
homogeneity prior to withdrawing a portion is important because some metals (e.g. Pb) are 
known to be associated mostly with the red blood cells in the specimen [5,38]. Blood with 
any observable clotting is unsuitable for analysis due to sample inhomogeneity. Whole blood 
samples are diluted 50× (1+1+48) with DI water and diluent (see Table 3), matching the 
blood and diluent composition of the working calibrators. Samples that exceed the 
concentration of the high calibrator are diluted extra (up to 20×) with DI water to bring them 
within the measurement range. The ratio of the volume of diluent to the total volume of the 
preparation must be constant across the preparations for the run because the diluent contains 
the internal standard. Samples which have been diluted 1+1+48 for analysis up to 24 h 
previously and stored at room temperature can still be analyzed. We observed a significant 
reduction in measured Hg and Se concentrations in diluted samples after 24 h.
3. Results and discussion
3.1. Spectral interferences and selectivity
In this method Pb, Cd and Hg do not require the use of DRC mode to reduce or remove 
spectral interferences, but each of these elements is measured with a mathematical equation 
in the ELAN® software for different reasons (see Table 2). 208Pb signal is summed with the 
signals from 206Pb and 207Pb to account for variation in relative abundances of lead isotopes 
in nature. The small natural abundance of 204Pb (1.4%) is not included in the sum because it 
does not vary and has an isobaric interference from 204Hg. The method uses a mathematical 
equation to correct for the small isobaric overlap of 114Sn (0.65%) on 114Cd. Molybdenum 
(Mo), an essential element, is present in human biological samples [7] and could interfere 
with blood 114Cd analysis as the 98Mo16O polyatomic ion. However, Mo is primarily 
excreted in the urine [39] and unless a blood sample is drawn within 24 h of an acute Mo 
exposure [40], we don’t expect a need for interference correction. Tungsten (W), not an 
essential element, has been measured in biological samples [7] and could interfere 
with 202Hg analysis as 186W16O and 184W18O polyatomic ions. However, humans primarily 
excrete W in urine [41], and we don’t expect a need for interference correction in blood 
samples due to the low reference values for blood W found in the literature (0.4 ng/g [42]). 
The method measures Hg in DRC mode with O2 gas in the reaction cell (Table 2) to take 
advantage of collisional focusing that increases the ion signal relative to vented mode (Fig. 
2), in addition to summing signal from 202Hg and 200Hg to increase Hg sensitivity. Other 
isotopes of Hg were excluded because of either isobaric interferences, low natural 
abundance, or an observed bias when included..
We use the ELAN® ICP-DRC-MS in DRC mode for the remaining two elements in the 
method, 55Mn and 80Se because of polyatomic interferences. The DRC conditions listed in 
Table 2 were selected based on the reduction/removal of the most severe spectral overlap for 
each isotope. Both isotopes suffer from plasma gas-based spectral overlaps: 40Ar2+ on 80Se+, 
and 40Ar14N1H+ and 38Ar16O1H+ on 55Mn+, among many others. Tables 4 and 5 list the 
other spectral interferences we considered for 55Mn and 80Se, respectively. This list is not 
comprehensive for all potential spectral overlaps at m/z 55 and 80. These species were 
selected based on the expected concentrations of elements in a diluted human blood sample. 
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Several times, the literature reports using CH4 as a reaction gas to remove the 40Ar2+ overlap 
from 80Se+ [43–45], but we could find only one report on the use of O2 as a reaction gas for 
measuring 55Mn+ [46] where the selection of O2 was based on the need to detect sulfur as 
the 32S16O+ product ion. NH3 is more commonly used as the reaction gas in a dynamic 
reaction cell [33,45], or He gas in a collision cell, for 55Mn+; however, we encountered a 
significant positive bias when attempting to use NH3 that we avoided by using oxygen as the 
DRC gas. Praamsma et al. [47] compared Mn results in blood from several sources including 
our laboratory and found that our Mn results with O2 gas were comparable to those obtained 
with NH3, sector field (SF)-ICP-MS, and graphite furnace atomic absorption spectrometry 
(GFAAS).
We performed selectivity testing for 55Mn and 80Se in the presence of potential spectral 
interferences by preparing samples in duplicate and adding a small spike of a potential 
interferent to one and the same volume spike of DI water to the other. We used single 
element spiking solutions at concentrations sufficiently high so that only a small volume 
spike (~0.1 mL) was required. We selected biological samples for testing that have a low-
normal concentration of the element of interest. The concentrations of some elements can 
vary greatly in biological samples; therefore, we tested high or elevated but still biologically 
relevant concentrations. These concentrations were found in the literature in reports of 
acutely exposed persons, or if known, the 95th percentile of a relevant population. We 
calculated the percent measured in a spiked sample relative to the unspiked sample. The 
percent recoveries for 55Mn and 80Se in Tables 4 and 5, respectively, were all within 6% of 
the non-spiked sample, proving that the DRC conditions are selective for 55Mn and 80Se 
even in the presence of high concentrations of potential interferents.
3.2. Accuracy and precision
Accuracy of an analytical method is best demonstrated by analysis of standard reference 
materials (SRM). NIST SRM 955c, “Toxic Metals in Caprine Blood,” is certified at four 
levels for Pb, Cd, and Hg, but none of the levels are certified for Mn or Se. A consensus 
value for Mn in Level 1 of 955c has been determined using data from several laboratories, 
including our own [47]. All four levels of the SRM were analyzed repeatedly over a four-
month time period, and the averaged results are shown in Table 6. The accuracy of the 
measurements with this method are within 5% of the target values. Level 1 is below the 
method LOD for Cd and Hg; therefore, the results are not listed in Table 6.
When no SRM exists for an element, we use reference materials (RM) which have 
previously been assigned target values through analysis by multiple labs to validate the 
accuracy of a method. Results for Mn and Se from analysis of RM samples from two 
programs are listed in Table 7. These samples were selected to cover a range of 
concentrations for the two elements. The accuracy of the method is demonstrated in the 
calculated percent bias of our results, which range from −7.8% to 1.3% for Mn, −6.8% to 
3.7% for Se, and an average bias of −2.6% and −1.9%, respectively.
We evaluated the run-to-run reproducibility of this method from the analysis of bench QC 
over 20 runs. The bench QC material is prepared in our laboratory by spiking human blood 
pools to desired concentrations. During the 20 run characterization process, we attempt to 
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capture what will be normal method variation in our laboratory. This includes rotation of 
calibrator lots, rotation of the analyst preparing samples, and performing maintenance on the 
instrument where sample introduction parts are either replaced, or cleaned and reinstalled. 
Also note that these limits were calculated with data from two different, yet equivalent, 
ELAN® DRC II ICP-MS instruments. This variation during characterization makes QC 
limits more rugged. Bench QC limits in Table 8 reflect percent CVs between 1% and 10% 
with the exception of the Elevated QC pool for Hg which has a percent CV of 14%.
3.3. Calibration range and limits of detection
The extension of the calibration curve added calibrators S6–S8 (see Table 3) to the method. 
We determined the concentration of the highest calibrator (S8) after considering input from a 
CDC medical toxicologist, typical concentrations of proficiency testing challenge samples, 
and concentrations we measured in our lab due to acute exposures [54]. Because the 
calibration range for each element spans 2.6 orders of magnitude we found that a weighted 
linear calibration curve was required to maintain accuracy at the low end of the calibration 
curve where we typically measure biomonitoring samples (see NHANES geometric mean in 
Table 3). The ELAN® software uses a 1/x2 weighted linear regression and typical correlation 
coefficients are greater than 0.99. No external data analysis is used.
Calculated method LODs are listed in Table 9. These values were calculated in a manner 
equivalent to the recommendations by the Clinical Laboratory Standards Institute (CLSI) 
which includes both Type I and Type II error in estimates of LOD [55] and further outlined 
in the DLS Policies and Procedures Manual [56]. These limits are derived from analysis of 
four low-concentration materials in at least 60 runs over a two-month timeframe. The four 
low-concentration materials were prepared per the method by spiking a known concentration 
of Standard 0, 1, 2 or 3 into the base blood matrix. The current and previous method LODs 
are listed in Table 9 for comparison, and the improvement in LODs for Pb, Cd, and Hg are 
due to the increase in sensitivity and precision of the new method.
3.4. Comparison of washout with two rinse solutions
The expanded calibration range allows for the application of this method to the measurement 
of Pb, Cd, Hg, Se, and Mn in human blood from acute and normal environmental exposures. 
Carryover from a high concentration sample might appear as measureable signal in the next 
sample, potentially making it a false positive result. Long rinse times can be used to 
minimize carryover, but at the expense of throughput. Proper selection of rinse composition 
and timing parameters are essential to minimize signal carryover and maximize throughput. 
The SC-FAST system was installed on the ELAN® DRC II ICP-MS prior to the expanded 
calibration range and used a method rinse time of only 30 s. We did not want to increase the 
rinse time to washout elevated samples the method was designed to handle with the 
expanded calibration range of the method.
We tested two rinse solutions to determine which one best reduced carryover after the 
system was exposed to high-concentration samples. One rinse solution, referred to here as 
EDTA+Au, was comprised of 1% Ethanol, 0.25% (v/v) TMAH, 0.05% Triton X-100™, 
0.01% EDTA, and 100 μg L−1 Au. It was based on a previous method used in our laboratory 
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[1] which measured only Pb, Cd, and Hg with calibrators up to S5 (see Table 3). The second 
rinse solution, referred to here as APDC, was comprised of 0.25% (v/v) TMAH, 0.05% 
Triton X-100™, 0.01% APDC, and 1% isopropanol. It was based on a method [26] which 
also quantified only Pb, Cd, and Hg but calibrated to higher concentrations: 200 μg dL−1, 
100 μg L−1, and 200 μg L−1, respectively. High concentration multi-element standards were 
prepared with concentrations up to 500 μg dL−1 (Pb), 1000 μg L−1 (Cd and Hg), 3000 μg 
L−1 (Mn), and 60,000 μg L−1 (Se).
After calibration, we measured several (N=8 or 9) matrix blank samples to determine the 
average matrix blank response for each element, then alternated between high concentration 
samples followed by five matrix blanks. We subtracted the averaged matrix blank 
concentration determined before the high concentration samples from the blanks measured 
after the high concentration samples to determine if any residual signal was attributable to 
carryover. The concentrations of the samples for the washout experiment were higher than 
Standard 8 for all elements. The high sample concentrations of Mn and Se did not exhibit 
any carryover (results not shown). Results for Pb, Cd, and Hg are displayed in Fig. 3. These 
results clearly show that the APDC rinse is superior in reducing signal carryover at the 
method rinse time of 30 s. A small amount of carryover (0.10 – 0.33 μg L−1) was observed 
after a 600 μg/L Hg or higher spike (three times higher than our highest calibrator). As 
additional protection against carryover, any sample with a concentration higher than the 
highest calibrator triggers an extended wash step (200 s) and analysts verify that the run is 
still in control for lower concentration samples before proceeding..
This same APDC reagent matrix was successfully adopted as the sample diluent for a short 
time. However, on occasion a precipitate would form when the calibrators were prepared 
(i.e. after mixing with diluent and base blood). Feng [57] reported that APDC will co-
precipitate metal ions at pH > 4, but not at pH < 4. At pH ≥7 Cd, and Hg did not co-
precipitate. We measured the pH of prepared calibrators with the TMAH concentration at 
0.25% (v/v) to be between 6.2 and 7.5. By increasing the TMAH concentration to 0.4% 
(v/v), we increased the pH of the prepared calibrators to > 7, and no precipitates have since 
been observed.
3.5. Validation of extra dilutions
Extra dilutions of specimens are required if the measured concentration is higher than the 
concentration of the highest calibrator. Dilutions of biological samples in ICP-MS can be 
problematic because modifying the matrix may interfere with matrix-matched calibration 
resulting in bias of observed concentrations. Sometimes extra dilutions are prepared by 
diluting with a “base” matrix; however, this step adds complications in practice because each 
level of extra dilution used in the run would require a separate matrix-matched blank.
We performed experiments that tested up to an extra 20× dilution of a blood sample. We 
spiked a base blood sample to final concentrations of 400 μg dL−1 (Pb), 100 μg L−1 (Cd and 
Hg), 300 μg L−1 (Mn), and 2000 μg L−1 (Se), and mixed the sample well. The spiked sample 
was then prepared for analysis at various extra dilution levels (2×–20×) with DI water. The 
experiment was repeated in separate runs on different days 6–8 times. Each result from an 
extra dilution (after multiplication by dilution factor) was normalized to the result with no 
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extra dilution from the same run. All normalized results for each dilution level were 
averaged (see Table 10) and indicate that all analytes of the method (Pb, Cd, Hg, Mn, and 
Se) can be analyzed at up to a 20× extra dilution without significant effect ( > ± 0.1 i.e. 10% 
change) to the observed concentration. These results support minimizing the extra dilution 
necessary to bring a sample within the calibration range.
These results are not intended support a non-matrix matched calibration. We tested extra 
sample dilutions and determined that the observed effect was acceptable for high 
concentration samples where medical intervention for the patient would be the same even 
with the observed effect. However, this effect would be highly significant in the 
biomonitoring range (i.e. lower concentrations). Matrix matching will result in the best 
accuracy for biomonitoring studies.
3.6. Transferability to other ICP-MS platforms
Because the ELAN ICP-DRC-MS is no longer produced by PE, we would like to offer our 
recommended criteria for performing the method described here on other ICP-MS platforms. 
We believe the information we provide on sample collection, treatment, diluent, and rinse 
solutions are all transferrable to other platforms. High analyte sensitivity, low background 
counts, measurement precision, and run-to-run reproducibility are important to achieve the 
LODs stated here. Low backgrounds for 55Mn and 80Se in human blood samples will only 
be achieved with the use of an interference removal technique. If a collision or other reaction 
cell is to be used, the cell must be capable of achieving a consistent sensitivity throughout 
the run and with varying cell ion densities. The peristaltic pump, or other sample 
introduction system, must be able to operate at the required low sample uptake rate without 
introducing noise to the ion signal for the best precision. Lastly, we recommend an 
instrument with a Fomblin fluid roughing pump to extend the time between required pump 
maintenance.
4. Conclusion
We developed a rugged method for analysis of whole blood samples for Pb, Cd, Hg, Se, and 
Mn on a PE ELAN® DRC II ICP-MS, using the vented mode for Pb and Cd, and two DRC 
modes to remove polyatomic spectral interferences from 55Mn and 80Se, and increase 
sensitivity for 202Hg. The sample-to-sample time of less than 5 min permits the preparation 
and analysis of 60 samples/8 h work day; limited by the length of a work shift. The 
improvements to this method include additional analytes (55Mn and 80Se), expanded 
calibration range, expanded reportable range using extra dilutions, optimized rinse and 
diluent components while maintaining short sample-to-sample times using the SC4-FAST 
system. The analytical metrics supplied demonstrate the method is selective, accurate (less 
than 8% bias relative to reference materials), and precise (percent CVs less than 14%), with 
a reportable range than spans more than 4 orders of magnitude, and improved LODs.
References
[1]. Caldwell KL, Mortensen ME, Jones RL, Caudill SP, Osterloh JD. Total blood mercury 
concentrations in the US population: 1999–2006. Int. J. Hyg. Environ. Health. 2009; 212:588–
598. [PubMed: 19481974] 
Jones et al. Page 10













[2]. Pirkle JL, Osterloh J, Needham LL, Sampson EJ. National exposure measurements for decisions to 
protect public health from environmental exposures. Int. J. Hyg. Environ. Health. 2005; 208:1–5. 
[PubMed: 15881972] 
[3]. Centers for Disease Control and Prevention. Fourth Report on Human Exposure to Environmental 
Chemicals, Updated Tables. U.S. Department of Health and Human Services, Centers for Disease 
Control and Prevention; Atlanta, GA: Feb. 2015 
[4]. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for Mercury. 
U.S. Department of Health and Human Services, Public Health Service; Atlanta, GA: 1999. 
[5]. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Lead. U.S. 
Department of Health and Human Services, Public Health Service; Atlanta, GA: 2007. 
[6]. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Cadmium. 
ATSDR. , editor. U.S Department of Health and Human Servies, Public Health Service; Atlanta, 
GA: 2012. 
[7]. Centers for Disease Control and Prevention. Fourth Report on Human Exposure to Environmental 
Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and 
Prevention; Atlanta, GA: 2009. http://www.cdc.gov/exposurereport/ [accessed 30.06.16]
[8]. Sommer YL, Verdon CP, Fresquez MR, Ward CD, Wood EB, Pan Y, Caldwell KL, Jones RL. 
Measurement of mercury species in human blood using triple spike isotope dilution with SPME-
GC-ICP-DRC-MS. Anal. Bioanal. Chem. 2014; 406:5039–5047. [PubMed: 24948088] 
[9]. CDC Response to Advisory Committee on Childhood Lead Poisoning Prevention 
Recommendations in “Low Level Lead Exposure Harms Children: A Renewed Call of Primary 
Prevention”. Atlanta, GA: Jun 7. 2012 
[10]. Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regul. Toxicol. 
Pharmacol. 2003; 38:232–242. [PubMed: 14550763] 
[11]. Combs GF, Gray WP. Chemopreventive agents: selenium. Pharmacol. Ther. 1998; 79:179–192. 
[PubMed: 9776375] 
[12]. Arthur JR. The role of selenium in thyroid-hormone metabolism. Can. J. Physiol. Pharmacol. 
1991; 69:1648–1652. [PubMed: 1804511] 
[13]. Corvilain B, Contempre B, Longombe AO, Goyens P, Gervydecoster C, Lamy F, Vanderpas JB, 
Dumont JE. Selenium and the thyroid: how the relationship was established. Am. J. Clin. Nutr. 
1993; 57:S244–S248.
[14]. McKenzie RC, Rafferty TS, Beckett GJ. Selenium: an essential element for immune function. 
Immunol. Today. 1998; 19:342–345. [PubMed: 9709500] 
[15]. Combs GE. Food system-based approaches to improving micronutrient nutrition: the case for 
selenium. Biofactors. 2000; 12:39–43. [PubMed: 11216503] 
[16]. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid 
metabolism: biochemistry and relevance to public health. Thyroid. 2002; 12:867–878. [PubMed: 
12487769] 
[17]. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for Selenium. 
ATSDR. , editor. U.S. Department of Health and Human Services, Public Health Service; 
Atlanta, GA: 2003. 
[18]. Saric, M.; Lucchini, R. Manganese. In: Nordberg, GF.; Fowler, BA.; Nordberg, M.; Friberg, LT., 
editors. Handbook on the Toxicology of Metals. Academic Press; Burlington, MA, USA: 2007. 
p. 645
[19]. Bader M, Dietz MC, Ihrig A, Triebig G. Biomonitoring of manganese in blood, urine and axillary 
hair following low-dose exposure during the manufacture of dry cell batteries. Int. Arch. Occup. 
Environ. Health. 1999; 72:521–527. [PubMed: 10592004] 
[20]. Woolf A, Wright R, Amarasiriwardena C, Bellinger D. A child with chronic manganese exposure 
from drinking water. Environ. Health Perspect. 2002; 110:613–616.
[21]. Wasserman GA, Liu XH, Parvez F, Ahsan H, Levy D, Factor-Litvak P, Kline J, van Geen A, 
Slavkovich V, Lolacono NJ, Cheng ZQ, Zheng Y, Graziano JH. Water manganese exposure and 
children’s intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 2006; 
114:124–129. [PubMed: 16393669] 
Jones et al. Page 11













[22]. Bazzi A, Nriagu JO, Linder AM. Determination of toxic and essential elements in children’s 
blood with inductively coupled plasma-mass spectrometry. J. Environ. Monit. 2008; 10:1226–
1232. [PubMed: 19244647] 
[23]. Rollin H, Mathee A, Levin J, Theodorou P, Wewers F. Blood manganese concentrations among 
first-grade schoolchildren in two South African cities. Environ. Res. 2005; 97:93–99. [PubMed: 
15476738] 
[24]. Davis JM, Jarabek AM, Mage DT, Graham JA. The EPA health risk assessment of 
methylcyclopentadienyl manganese tricarbonyl (MMT). Risk Anal. 1998; 18:57–70. [PubMed: 
9523444] 
[25]. Institute of Medicine (US) Panel on Micronutrients. Dietary Reference Intakes for Vitamin A, 
Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, 
Silicon, Vanadium, and Zinc. National Academies Press (US); Washington, DC: 2001. p. 
394-419.Available from: 〈http://www.ncbi.nlm.nih.gov/books/NBK222310/〉 http://:dx.doi.org/
10.17226/10026 [accessed 30.06.16]
[26]. McShane WJ, Pappas RS, Wilson-McElprang V, Paschal D. A rugged and transferable method 
for determining blood cadmium, mercury, and lead with inductively coupled plasma-mass 
spectrometry, Spectrochim. Acta Part B:- At. Spectrosc. 2008; 63:638–644.
[27]. Ivanenko NB, Ganeev AA, Solovyev ND, Moskvin LN. Determination of trace elements in 
biological fluids. J. Anal. Chem. 2011; 66:784–799.
[28]. D’Ilio S, Violante N, Di Gregorio M, Senofonte O, Petrucci F. Simultaneous quantification of 17 
trace elements in blood by dynamic reaction cell inductively coupled plasma mass spectrometry 
(DRC-ICP-MS) equipped with a high-efficiency sample introduction system. Anal. Chim. Acta. 
2006; 579:202–208. [PubMed: 17723744] 
[29]. Palmer CD, Lewis ME Jr, Geraghty CM, Barbosa F Jr, Parsons PJ. Determination of lead, 
cadmium and mercury in blood for assessment of environmental exposure: a comparison between 
inductively coupled plasma-mass spectrometry and atomic absorption spectrometry. 
Spectrochimica Acta - Part B, At. Spectrosc. 2006; 61:980–990.
[30]. Heitland P, Koster HD. Biomonitoring of 37 trace elements in blood samples from inhabitants of 
northern Germany by ICP-MS. J. Trace Elem. Med. Biol. 2006; 20:253–262. [PubMed: 
17098585] 
[31]. Nixon DE, Neubauer KR, Eckdahl SJ, Butz JA, Burritt MF. Comparison of tunable bandpass 
reaction cell inductively coupled plasma mass spectrometry with conventional inductively 
coupled plasma mass spectrometry for the determination of heavy metals in whole blood and 
urine. Spectrochim. Acta Part B: At. Spectrosc. 2004; 59:1377–1387.
[32]. Lu Y, Kippler M, Harari F, Grandér M, Palm B, Nordqvist H, Vahter M. Alkali dilution of blood 
samples for high throughput ICP-MS analysis—comparison with acid digestion. Clin. Biochem. 
2015; 48:140–147. [PubMed: 25498303] 
[33]. Praamsma ML, Arnason JG, Parsons PJ. Monitoring Mn in whole blood and urine: a comparison 
between electrothermal atomic absorption and inorganic mass spectrometry. J. Anal. At. 
Spectrom. 2011; 26:1224–1232.
[34]. Lutz TM, Nirel PMV, Schmidt B. Whole blood analysis by ICP-MS, applications of plasma 
source mass spectrometry. R. Soc. Chem. 1991:96–100.
[35]. Caudill SP, Schleicher RL, Pirkle JL. Multi-rule quality control for the age-related eye disease 
study. Stat. Med. 2008; 27:4094–4106. [PubMed: 18344178] 
[36]. Jarrett JM, Jones RL, Caldwell KL, Verdon CP. Total urine arsenic measurements using 
inductively coupled plasma mass spectrometry with a dynamic reaction cell. At. Spectrosc. 2007; 
28:113–122.
[37]. McShane WJ, Pappas RS, Paschal D. Analysis of total arsenic, total selenium and total chromium 
in urine by inductively coupled plasma-dynamic reaction cell-mass spectrometry. J. Anal. At. 
Spectrom. 2007; 22:630–635.
[38]. Barbosa F Jr, Tanus-Santos JE, Gerlach RF, Parsons PJ. A critical review of biomarkers used for 
monitoring human exposure to lead: advantages, limitations, and future needs. Environ. Health 
Perspect. 2005; 113:1669–1674. [PubMed: 16330345] 
Jones et al. Page 12













[39]. Turnlund, JR.; Friberg, LT. Molybdenum. In: Nordberg, GF.; Fowler, BA.; Nordberg, M.; Friberg, 
LT., editors. Handbook on the Toxicology of Metals. Academic Press; Burlington, MA, USA: 
2007. p. 731-741.
[40]. Carson, B.; Ellis, HI.; McCann, J. Toxicology and Biological Monitoring of Metals in Humans. 
Lewis Publishers, Inc.; Chelsea, MI: 1986. 
[41]. Kazantzi, G.; Leffer, P. Tungsten. In: Nordberg, GF.; Fowler, BA.; Nordberg, M.; Friberg, LT., 
editors. Handbook on the Toxicology of Metals. Academic Press; Burlington, MA, USA: 2007. 
p. 871-879.
[42]. Leroy, MJF.; Lagarde, F. TungstenHandbook on Metals in Clinical and Analytical Chemistry. 
Marcel Dekker, Inc.; 1994. 
[43]. Rowan JT, Houk RS. Attenuation of polyatomic ion interferences in inductively coupled plasma 
mass-spectrometry by gas-phase collisions. Appl. Spectrosc. 1989; 43:976–980.
[44]. Sloth JJ, Larsen EH. Application of inductively coupled plasma dynamic reaction cell mass 
spectrometry for measurement of selenium isotopes, isotope ratios and chromatographic 
detection of selenoamino acids. J. Anal. At. Spectrom. 2000; 15:669–672.
[45]. Fong BMW, Siu TS, Lee JSK, Tam S. Multi-elements (aluminium, copper, magnesium, 
manganese, selenium and zinc) determination in serum by dynamic reaction cell-inductively 
coupled plasma-mass spectrometry. Clin. Chem. Lab. Med. 2009; 47:75–78. [PubMed: 
19055466] 
[46]. Hann S, Koellensperger G, Obinger C, Furtmüller PG, Stingeder G. SEC-ICP-DRCMS and SEC-
ICP-SFMS for determination of metal-sulfur ratios in metallo-proteins. J. Anal. At. Spectrom. 
2004; 19:74–79.
[47]. Praamsma ML, Jones DR, Jarrett JM, Dumas P, Cirtiu CM, Parsons PJ. A comparison of clinical 
laboratory data for assigning a consensus value for manganese in a caprine blood reference 
material. J. Anal. At. Spectrom. 2012; 27:1975–1982. [PubMed: 26290619] 
[48]. Scott, MG.; Heusel, JW.; LeGrys, VA.; Siggaard-Andersen, O. Electrolytes and Blood gases. In: 
Burtis, CA.; Ashwood, ER., editors. Tietz Textbook of Clinical Chemistry. W.B. Saunders 
Company; 1999. p. 1056-1092.
[49]. Alexander, NM. Iron. In: Seiler, HG.; Sigel, A.; Sigel, H., editors. Handbook on Metals in 
Clinical and Analytical Chemistry. Marcel Dekker, Inc.; New York, New York: 1994. p. 411-421.
[50]. Painter, PC.; Cope, JY.; Smith, JL. Reference information for the clinical laboratory. In: Burtis, 
CA.; Ashwood, ER., editors. Tietz Textbook of Clinical Chemistry. W.B. Saunders Company; 
1999. p. 1788-1846.
[51]. Centers for Disease Control and Prevention, National Center for Health Statistics. Measured 
average height, weight, and waist circumference for adults ages 20 years and over. U.S. 
Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta, 
GA: 2014. http://www.cdc.gov/nchs/fastats/body-measurements.htm [accessed 12.12.14]
[52]. Jin, T.; Berlin, M. Titanium. In: Nordberg, GF.; Fowler, BA.; Nordberg, M.; Friberg, LT., editors. 
Handbook on the Toxicology of Metals. Academic Press; Burlington, MA, USA: 2007. p. 
861-870.
[53]. Thunus, L.; Lejeune, R. Zinc. In: Seiler, HG.; Sigel, A.; Sigel, H., editors. Handbook on Metals 
in Clinical and Analytical Chemistry. Marcel Dekker, Inc.; New York, New York: 1994. p. 
667-674.
[54]. Dooyema CA, Neri A, Lo YC, Durant J, Dargan PI, Swarthout T, Biya O, Gidado SO, Haladu S, 
Sani-Gwarzo N, Nguku PM, Akpan H, Idris S, Bashir AM, Brown MJ. Outbreak of fatal 
childhood lead poisoning related to artisanal gold mining in northwestern Nigeria, 2010. Environ. 
Health Perspect. 2012; 120:601–607. [PubMed: 22186192] 
[55]. CLSI. Evaluation of Detection Capability for Clinical Laboratory Measurements Procedures; 
Approved Guideline – Second Edition. In: Pierson-Perry, JF.; Vaks, JE.; Durham, AP.; Fischer, 
C.; Gutenbrunner, C.; Hillyard, D.; Kondratovich, MV.; Ladwig, P.; Middleberg, RA., editors. 
CLSI document EP17-A2. Clinical and Laboratory Standards Institute; Wayne, PA: 2012. 
[56]. Centers for Disease Control and Prevention. Division of Laboratory Sciences Policies and 
Procedures Manual. Atlanta, GA: May. 2015 Available from: 〈http://intranet.cdc.gov/nceh-
atsdr/dls/pdf/05/DLS_Policies_and_Procedures_Manual.pdf〉
Jones et al. Page 13













[57]. Feng X, Ryan DE. Combination collectors in adsorption colloid flotation for multielement 
determination in waters by neutron activation. Anal. Chim. Acta. 1984; 162:47–55.
Jones et al. Page 14














Comparison of (a) new hydrocarbon pump oil to (b) hydrocarbon pump oil after 40 days of 
use (approximately 25 analytical runs).
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202Hg signal versus O2 gas flow rate in the dynamic reaction cell showing collisional 
focusing of the 202Hg signal (●) 3% (v/v) HCl, (○) 0.5 μg/L Hg in 3% (v/v) HCl, (– 
–) 202Hg signal normalized to vented mode.
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Comparison of (•) EDTA + Au to (○) APDC for washout of high concentrations of (a) Cd, 
(b) Hg, and (c) Pb; some blank samples in the numerical sequence are not displayed.
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Table 1
Instrument parameters for the PE ELAN® DRC II ICP-MS.
Instrument parameter Value/setting
RF power 1.45 kW
Plasma gas flow (Ar) 15 L min−1
Auxiliary gas flow (Ar) 1.2 L min−1
Nebulizer gas flow (Ar) ~0.90 to 1.0 L min−1




Dwell time(s) 100 ms For analytes (Se, Mn, Hg, Cd, Pb)
50 ms For internal standards (Rh, Te, Ir)
Ion lens voltage(s) AutoLens™
Detector mode Dual
Calibration Regression Type External, matrix matched, weighted linear
a
Rinse time 30 s
DRC pressurize delay 60 s
DRC exhaust delay 30 s
DRC channel delay 30 s
a
The ELAN software uses a (1/x2) weighting.
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Table 2
Analyte, internal standards, equations, and DRC parameters.
Isotope Internal standard Equation Mode (DRC or vented) Gas Flow rate (mL min−1) RPq RPa
80Se 130Te None DRC, Channel A CH4 0.84 0.65 0
55Mn 103Rh None DRC, Channel B O2 1.2 0.6 0
202Hg 130Te +200Hg DRC, Channel B O2 1.2 0.6 0
114Cd 193Ir −0.027250*118Sn Vented NA NA 0.25 0
208Pb 193Ir +206Pb, +207Pb Vented NA NA 0.25 0
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Table 4
Selectivity testing results for 55Mn+ in the presence of interfering species.
Spectral interference for
55Mn+
Highest anticipated conc. in 
human
whole blood








110Cd++ 1.30 μg L−1 Cd
a 12 μg L−1 Cd 99% 98%
39K16O+ 200 mg L−1K
b 200 mg L−1 K 101% 97%




 Cl 100% 99%
54Fe1H+ 405 mg L−1 Fe
d 500 mg L−1 Fe 103% 99%
a
95th Percentile from NHANES 1999–2002 survey [7].
b
Calculated from a reference value of 5.1 mmol/L K in adult serum [48].
c
Calculated from a reference value of 108 mmol/L Cl in plasma [48].
d
Calculated from reference value of 2700 mg Fe in an adult human [49] 75 mL/kg of blood in an adult (range of 50 – 83 mL/kg) [50]; average 
adult weight of 88.8 kg [51].
α
3% HCl matrix (v/v).
¥
Results calculated as measured Mn concentration in spiked sample relative to unspiked base blood or CTQ reference material. Average measured 
base blood Mn concentration was 8.5 μg L−1; Average measured QMEQAS09B-02 Mn concentration was 10.2 μg L−1.
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Table 5
Selectivity testing results for 80Se+ in the presence of interfering species.













Se recovery in spiked
QMEQAS07B0-09
¥
64Ni16O+ 0.028 mg L−1 Ni [50] 0.300 mg L−1 Ni 98% 96% 100%
64Ni12C1H4+
48Ti16O2+ 0.150 mg L−1 Ti
a 1.5 mg L−1 Ti 100% 95% 100%
48Ti(12C1H4)2+
63MCu17O+ 1.5 mg L−1 Cu [50] 15 mg L−1 Cu 99% 94% 102%
64Zn16O+ 7.18 mg L−1 Zn
b 7 mg L−1 Zn 101% 95% 100%
64Zn12C1H4+
40Ca40Ar+ 86–100 mg L
−1 Ca in 
serum [50] 500 mg L
−1 Ca 102% 97% 102%
40K40Ar+ 200 mg L−1 K
c 200 mg L−1 K 101% 97% 102%
a
Calculated from upper value of 0.15 mg/kg (ppm) [52].
b




Results calculated relative to unspiked base blood, QC, or CTQ reference material. Average measured Se concentration in base blood was 268 μg 
L−1. Average measured Se concentration in low QC pool was 215 μg L−1. Average measured Se concentration in QMEQAS07B-09 was 169 μg 
L−1.
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Table 6









( ± 1 SD)
% Bias
Level 1 Pb (μg dL−1) 0.424 ± 0.011
a 0.441 ± 0.024 4.0%
Level 2 13.95 ± 0.08
a 13.7 ± 0.3 −1.8%
Level 3 27.76 ± 0.16
a 27.4 ± 0.5 −1.3%
Level 4 45.53 ± 0.27
a 44.4 ± 1.3 −1.9%
Level 2 Cd (μg L−1) 2.14 ± 0.24
b 2.11 ± 0.08 −1.4%
Level 3 5.201 ± 0.038
a 5.14 ± 0.19 −1.2%
Level 4 9.85 ± 0.17
b 9.98 ± 0.39 1.3%
Level 2 Hg (μg L−1) 4.95 ± 0.76
b 5.19 ± 0.20 4.8%
Level 3 17.8 ± 1.6
a 18.4 ± 0.7 3.3%
Level 4 33.9 ± 2.1
b 33.5 ± 1.7 −1.3%
Level 1 Mn (μg L−1) 16.3 ± 0.8








Expanded uncertainty at approximately 95% confidence level.
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Table 7








conc. ( ± 1 SD)
% Bias N
QMEQAS08B-05
a Mn (μg L−1) 9.3 ± 0.62 9.17 ± 0.55 −1.4% 15
BE11-03
b 13.2 ± 1.6 13.3 ± 0.9 0.4% 8
QMEQAS08B-08
a 17.7 ± 1.2 16.3 ± 0.8 −7.8% 15
QMEQAS10B-03
a 21.6 ± 1.4 20.7 ± 1.0 −4.3% 15
QMEQAS10B-06
a 41.2 ± 3.4 41.7 ± 2.7 1.3% 8
BE10-12
b 54.1 ± 4.8 54.1 ± 2.9 −0.1% 8
QMEQAS08B-08
a Se (μg L−1) 165 ± 11 157 ± 9 −5.0% 15
QMEQAS10B-06
a 239 ± 19 248 ± 11 3.7% 8
QMEQAS08B-05
a 260 ± 17 242 ± 12 −6.8% 15
BE10-14
b 367 ± 28 372 ± 14 1.3% 8
BE11-03
b 421 ± 43 416 ± 17 −1.3% 8
QMEQAS10B-03
a 627 ± 42 606 ± 28 −3.4% 15
a
Sample from CTQ (Quebec, Canada).
b
Sample from the Wadsworth Center (Albany, NY).
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Table 8











Pb (μg dL−1) 2.11 ± 0.07 10.0 ± 0.1 88.2 ± 1.5
Cd (μg L−1) 0.459 ± 0.041 3.05 ± 0.09 44.8 ± 1.2
Hg (μg L−1) 0.603 ± 0.056 5.89 ± 0.15 41.8 ± 5.9
Mn (μg L−1) 8.44 ± 0.45 14.6 ± 0.6 42.9 ± 1.8
Se (μg L−1) 190 ± 6 252 ± 8 2662 ± 100
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Table 9
Method limits of detection for Pb, Cd, Hg, Mn, and Se in whole, human blood.
Element Limit of Detection Previous LOD[1]
Pb 0.07 μg dL−1 0.25 μg dL−1
Cd 0.10 μg L−1 0.20 μg L−1
Hg 0.28 μg L−1 0.33 μg L−1
Mn 0.99 μg L−1 N/A
Se 24 μg L−1 N/A













Jones et al. Page 27
Table 10
Normalized observed mean concentrations of each element measured with extra dilution factors. DI water was 
used to perform the extra dilution.
Dilution level Mn Hg Se Cd Pb
No Extra (N=8) 1.00 1.00 1.00 1.00 1.00
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